Mesquita M, Leszczynska a, Llorenç V, Adán a (2014) bloqueio interleucina-6 na doença inflamatória ocular. Clin Exp Ophthalmol 176: 301-309.Cronau H (2010) diagnóstico e gestão do olho vermelho nos cuidados primários. Am Fam Physician 81: 137-144.Song J, Huang YF, Zhang WJ, Chen XF, Guo YM (2016) Ocular Diseases: Immunological and molecular mechanisms. Int J Ophthalmol 9: 780-788., Bora NS, Gbleman CL, Atkinson JP, Pepose JS, Kaplan hj (1993) Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 34: 851-855.Jha P, Bora PS, Bora NS (2007) o sistema complementar e as doenças oculares. Mol Immunol 44: 3901-3908. Bielory L, Katlaris CH, Lightman S, Naclerio RM (2007), que trata o componente ocular da rinoconjuntivite alérgica e distúrbios oculares relacionados. MedGenMed 9: 35-46.Behlau I, Gilmore MS (2008) Microbial biofilms in ophthalmology and infectious disease., Arch Ophthalmol 126: 1572-1581. Szczotka-Flynn L, Imamura Y, Chandra J, Yu C, Mukherjee PK, et al. (2009) Increased resistance of contact lens-related bacterian biofilms to anti-microbial activity of soft contact lens care solutions. Cornea 28: 918-926. Mukherjee P (2005) Candida biofilm: a well-designed protected environment. Med Mycol 43: 191-208.